Market Place
Sourcing Support
Alembic Q2 Profit Rises 21% on Robust Us Generics & API Growth
04 Nov 2025 //
BUSINESS STD
Alembic And Amlan Launch Feed Additive Solutions For Poultry
07 Oct 2025 //
INDPHARMAPOST
Alembic Pharmaceuticals Q1 Fy26 Revenue up 10%; Net Profit up 15%
06 Aug 2025 //
INDPHARMAPOST
Alembic Pharma Acquires Utility Therapeutics for $12 Million
05 Jul 2025 //
INDPHARMAPOST
Alembic Pharmaceuticals Q4 FY25 PAT at Rs. 156.63 Cr
06 May 2025 //
INDPHARMAPOST
Alembic Pharma Q4 profit down 12%, revenue up 17% to Rs 1,770 cr
06 May 2025 //
BUSINESS STD
Briefs: Alembic Pharmaceuticals and Bafna Pharmaceuticals
01 May 2025 //
INDPHARMAPOST
Alembic Pharma slides after Q3 PAT tumble 23% YoY to Rs 138 crore
03 Feb 2025 //
BUSINESS STD
Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds
03 Feb 2025 //
BUSINESS STD
India`s Alembic posts lower Q3 profit on weak domestic demand
03 Feb 2025 //
REUTERS
Alembic Pharma Buzzes in Trade on December 20
20 Dec 2024 //
BUSINESS STD
Alembic Gains Guinness World Record for Hypertension Awareness
25 Nov 2024 //
EXPRESSPHARMA
Alembic Pharma Q2 FY25 PAT up 12% to Rs. 153 Cr
07 Nov 2024 //
INDPHARMAPOST
Alembic Pharma announces Joining of PM`s Internship Scheme Early
07 Oct 2024 //
EXPRESSPHARMA
Alembic Pharmaceuticals Ltd leads losers in `A` group
09 Aug 2024 //
BUSINESS STANDARD
Indian drugmaker Alembic Pharma posts Q1 profit rise on strong US sales
07 Aug 2024 //
REUTERS
Alembic Nelarabine injection gets FDA final approval
05 Aug 2024 //
ECONOMICSTIMES
Alembic`s Generics Fluphenazine HCl Receives Approval in US
22 Jul 2024 //
FDA
Alembic Pharma gets tentative nod from USFDA for Ivosidenib tablets
05 Jul 2024 //
ECONOMIC TIMES
Alembic Pharma gets USFDA final approval for Dabigatran Etexilate capsules
19 Jun 2024 //
INDIANPHARMAPOST
Alembic receives USFDA final approval for Sacubitril and Valsartan Tablets
29 May 2024 //
INDINPHARMAPOST
Alembic Pharma net profit up by 16% in Q4, dividend at 550%
13 May 2024 //
PHARMABIZ
Alembic Pharmaceuticals posts Q4 FY24 PAT at Rs. 178.21 Cr
09 May 2024 //
INDINPHARMAPOST
Alembic Pharmaceuticals appoints Manish Kejriwal as Independent Director
02 Apr 2024 //
INDIANPHARMAPOST
Alembic Pharma gets tentative USFDA nod for breast cancer drug
02 Apr 2024 //
ECONOMICTIMES
Manufacturing operations disrupted at Sikkim plant due to flash floods: Alembic
04 Oct 2023 //
ECONOMIC TIMES
Alembic aims for US rebound with new launches
16 Aug 2023 //
ECONOMIC TIMES
Alembic Q4 FY23 consolidated PAT up at Rs. 48.25 Cr
13 May 2023 //
INDIAN PHARMA POST
Alembic Pharmaceuticals gets USFDA nod for hypertension drug
08 Mar 2023 //
ECONOMIC TIMES
Alembic Pharma gets USFDA nod for Fluorouracil Injection USP, 2.5 g/50 Ml
06 Mar 2023 //
EXPRESS PHARMA
Alembic Pharmaceuticals Q3 FY23 revenue up 19% to Rs. 1,509 Cr
06 Feb 2023 //
INDIAN PHARMA POST
Alembic gets USFDA nod for generic skin treatment cream
09 Dec 2022 //
ECONOMIC TIMES
Alembic Pharma gets USFDA nod for generic drug
02 Dec 2022 //
MONEYCONTROL
Alembic Pharmaceuticals gets final USFDA approval for Cyclophosphamide capsules
14 Nov 2022 //
HEALTH ET
Alembic receives final approval from USFDA for generic Mesalamine ER capsules
01 Nov 2022 //
ECONOMICTIMES
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
01 Nov 2022 //
INDIATIMES.COM/INDUSTRY/HEALTHCARE/BIOTE
Alembic Pharma gets USFDA nod for generic injection to treat cancer
27 Oct 2022 //
ECONOMICTIMES
USFDA concludes inspection at Alembic Pharmas Bioequivalence Facility
27 Oct 2022 //
INDISINFOLINE
Alembic Pharmaceuticals Gujarat facility gets observations from USFDA
02 Sep 2022 //
ECONOMIC TIMES
Alembic Pharma gets USFDA approval for chlorthalidone tablets
29 Aug 2022 //
HEALTH ET
Alembic Pharma subsidiary, Aleor Dermaceuticals gets USFDA nod for acne gel
08 Aug 2022 //
ET HEALTH
Alembic Pharmaceuticals reclassifies Dividend
06 Aug 2022 //
BUSINESS-STANDARD
Aleor Dermaceuticals gets USFDA approval for Diclofenac Sodium Topical Gel
29 Jul 2022 //
EXPRESS PHARMA
BMS Settles Patent Dispute With Alembic Over Blockbuster Revlimid
11 Jul 2022 //
FDANEWS
Alembic gets USFDA nod for cancer treatment drug
10 Jun 2022 //
ECONOMIC TIMES
Alembic Pharma gets USFDA approval to market Pirfenidone tablets
24 May 2022 //
BUSINESS-STANDARD
Cosette Pharma, Alembic Pharma Announce the Approval and Launch of NBE of Abreva
24 May 2022 //
BUSINESSWIRE
Alembic Pharma gets final USFDA nod for generic version of Arformoterol Tartrate
11 May 2022 //
MONEYCONTROL
Aleor Dermaceuticals receives final USFDA approval for cold sore drug
04 May 2022 //
ET HEALTH
Alembic reports 11 per cent growth in revenue for Q4 FY22
02 May 2022 //
ET HEALTH
AZ has defended Tagrisso from generics. But for how long?
27 Apr 2022 //
FIERCEPHARMA
Alembic gets USFDA nod to market generic drug
20 Apr 2022 //
ECONOMIC TIMES
Alembic Pharma buys out partner stake in Aleor Dermaceuticals
30 Mar 2022 //
ECONOMIC TIMES
Alembic Pharma targets 10-12 product filings from Karkhadi facility
26 Mar 2022 //
BUSINESS-STANDARD
Alembic gets US FDA tentative nod for macitentan tablets
14 Mar 2022 //
PHARMABIZ
Alembic Pharmaceuticals` JV gets USFDA final nod for anti-fungal drug
08 Mar 2022 //
ECONOMIC TIMES
Alembic Pharma posts 40% drop in Q3 net profit at Rs. 176 crore
11 Feb 2022 //
PHARMABIZ
Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate ER tablets
02 Feb 2022 //
ECONOMIC TIMES
Alembic gets USFDA approval to market Clarithromycin tablets in America
01 Feb 2022 //
ECONOMIC TIMES
Alembic Pharma gets tentative USFDA approval for depressive disorder drug
07 Jan 2022 //
ECONOMIC TIMES
